E-mail: maly@fnhk.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- ACHIEVEMENT OF BCL-2/IGH NEGATIVITY IN PERIPHERAL BLOOD/BONE MARROW IS ASSOCIATED WITH BETTER CLINICAL OUTCOME IN PATIENTS WITH FOLLICULAR LYMPHOMA
- Angiogeneze u chronické lymfocytární leukémie.
- ANGIOGENIC CYTOKINES IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: ASSOCIATION WITH IGVH MUTATION STATUS AND GENETIC ABNORMALITIES
- Angiogenní cytokiny u chronické B-lymfocytární leukémie: souvislost s moderními prognostickými faktory
- Angiogenní faktory bFGF, VEGF a sCD105 jsou zvýšeny u chronické B-lymfocytární leukémie.
- Angiopoietin-2 mRNA Expression Is Elevated in Chronic Lymphocytic Leukemia Patients with Poor Prognostic Features
- ANGIOPOIETIN-2 MRNA EXPRESSION IS INCREASED IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH UNMUTATED IGVH GENES
- Association of IgVH mutation status and plasma levels of angiogenic activators in chronic lymphocytic leukaemia: significantly higher bFGF but not VEGF in IgVH mutated patients
- ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS OF TRANSPORT PROTEINS SLC22A1, ABCB1 AND ABCG2 WITH RESPONSE TO IMATINIB AND IMATINIB PLASMA LEVEL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
- ASSOCIATION OF ZAP-70 EXPRESSION WITH PLASMA LEVELS OF ANGIOGENIC ACTIVATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
- BASIC FIBROBLAST GROWTH FACTOR (BFGF) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ARE ELEVATED IN PATIENTS WITH EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA.
- Bone Marrow Angiogenesis in Chronic Lymphocytic Leukemia: Relationship to Classical and Modern Prognostic Factors
- BONE MARROW/PERIPHERAL BLOOD POSITIVITY OF BCL-2/IGH REARRANGEMENT IN PATIENTS WITH FOLLICULAR LYMPHOMA BEFORE TREATMENT HAS NO PROGNOSTIC SIGNIFICANCE
- CARDIAC BIOMARKERS AND ASSESSMENT OF CARDIAC TOXICITY DURING HEMATOPOIETIC CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES
- Circulating Angiogenic Cytokines in Chronic Lymphocytic Leukemia: Relationship to Modern Prognostic Factors and Effect of Fludarabine-Based Treatment
- DETECTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY WITH CARDIAC TROPONINS AND ECHOCARDIOGRAPHY
- Elektrokardiografické změny v souvislosti s onkologickou léčbou
- ENDOGLIN AS A NEW BIO INDICATOR OF HAEMORHEOPHERESIS/IMMUNOAPHERESIS PROCEDURE EFFICIENCY
- ENDOTHELIAL MICROPARTICLES AND MARKERS OF COPPER METABOLISM AS NOVEL INDICATORS OF ANGIOGENESIS IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA.
- EVALUATION OF PLASMA CYTOKINE LEVELS BY BIOCHIP ARRAY TECHNOLOGY IN ACUTE MYELOID LEUKEMIA PATIENTS. A PILOT STUDY
- Exprese fibroblastového růstového faktoru 2 u pacientů s chronickou lymfocytární leukemií
- GLYCOGEN PHOSPHORYLASE BB AS A POTENTIAL MARKER OF CARDIAC TOXICITY IN PATIENTS TREATED WITH ANTHRACYCLINES FOR ACUTE LEUKEMIA
- HAEMORHEOPHERESIS IN THE TREATMENT OF MICROCIRCULATORY DISORDERS
- HIGH ON-TREATMENT PLATELET REACTIVITY: NOT AN ISOLATED PROBLEM
- CHANGES OF HAEMOSTASIS INDUCED BY LDL-APHERESIS
- CHRONIC EOSINOPHILIC LEUKEMIA ASSOCIATED WITH T(5;16)(Q32;P13) SENSITIVE TO IMATINIB
- INFECTION TRANSMISSION DURING GRAFT IN STEM CELL TRANSPLANTATION – SYSTEM OF PREVENTION
- INVESTIGATION OF PRIMARY HEMOSTASIS USING PFA-100 ANALYZER
- IS COMBINATION OF FOUR CYCLES OF EBEACOPP AND FOUR CYCLES OF BBEACOPP APPROPRIATE TREATMENT OPTION FOR PATIENTS WITH ADVANCED STAGE HODGKIN´S LYMPHOMA?
- IS DETECTION OF CYP3A5*3 ALLELE IN CHRONIC MYELOID LEUKEMIA PATIENTS PRIOR TO TREATMENT WITH IMATINIB MESYLATE RELEVANT?
- Kardiální biomarkery a hodnocení kardiotoxicity v onkologii.
- Komplexní hodnocení angiogeneze u chronické lymfocytární leukémie
- Komplexní hodnocení angiogeneze u chronické lymfocytární leukémie.
- LONG-TERM TREATMENT OF SEVERE MYASTHENIA GRAVIS BY EXTRACORPOREAL IMMUNOGLOBULIN ELIMINATION
- MEAN PLATELET VOLUME DECREASED AFTER IMMUNOAPHERESIS OR CASCADE PLASMA FILTRATION THERAPY IN FAMILIAL HYPERCHOLESTEROLEMIA
- MECHANISMS AND CLINICAL IMPORTACE OF STATIN DROP AFTER EXTRACORPOREAL LDL-CHOLESTEROL ELIMINATION
- MONITORING OF CARDIOTOXICITY DURING HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE LEUKEMIA
- MULTIPLE BIOMARKER USE FOR EVALUATION OF TREATMENT-RELATED CARDIOTOXICITY IN ACUTE MYELOID LEUKEMIA. A PILOT STUDY
- Nutnost opakované chirurgické intervence v průběhu akutní myeloidní leukemie u mladé ženy.
- ORAL FLUDARABINE AND CYCLOPHOSPHAMIDE PLUS RITUXIMAB (FCR) IS A SAFE AND EFFECTIVE SALVAGE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA AND FOLLICULAR LYMPHOMA.
- Plasma concentrations of angiogenic activators VEGF and bFGF in patients with multiple myeloma, follicular lymphoma, diffuse large B-cell lymphoma, and chronic myeloid leukemia
- PLASMA CYTOKINE AND ADHESION MOLECULE PROFILE IN PATIENTS TREATED FOR ACUTE MYELOID LEUKEMIA
- PLASMA EXCHANGE IN THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA – ONE CENTRE EXPERIENCE
- PLASMA LEVELS OF SOLUBLE ENDOGLIN HAVE PROGNOSTIC SIGNIFICANCE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
- Plasma soluble endoglin (sCD105) concentrations in patients with lymphoid malignancies – a pilot study
- Plazmatické koncentrace solubilního endoglinu mají prognostický význam u nemocných s chronickou lymfocytární leukémií
- Primární CNS lymfomy - zkušenosti centra
- PROCOAGULANT ACTIVITY OF CIRCULATING MICROPARTICLES IN HEMODIALYSIS PATIENTS
- PROGNOSTIC INFLUENCE OF ELEVATED PRETRANSPLANT SERUM FERRITIN ON THE RESULTS AFTER ALLOGENIC HEMATOPOETIC STEM CELL TRANSPLANTATION
- Progresivní multifokální leukoencefalopatie - vzácná komplikace po podání chemoterapie a rituximabu u nemocného s lymfomem
- Progresivní multifokální leukoencefalopatie – vzácná komplikace po podání chemoterapie a rituximabu u nemocného s lymfomem
- RETROSPECTIVE ANALYSIS OF TREATMENT OF PRIMARY PROGRESSIVE AND/OR RELAPSED HODGKIN’S DISEASE IN 1996 - 2004
- Rezistence na kyselinu acetylosalicylovou u hemodialyzovaných pacientů
- Richterův syndrom – současný pohled na diagnostiku a léčbu
- RITUXIMAB IMPROVES OUTCOME IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA. A SINGLE CENTRE RETROSPECTIVE STUDY
- RITUXIMAB INFUSION-RELATED TOXICITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
- Safety precautions against infection transmission during stem cell transplantation
- Současný pohled na léčbu nemocných s folikulárním B-nehodgkinovým lymfomem, nové trendy v léčbě tohoto onemocnění
- Successful Treatment with Imatinib Mesylate Significantly Decreases Plasma Levels of Vascular Endothelial Growth Factor (VEGF) and Soluble Endoglin (sCD105) but Not Basic Fibroblast Growth Factor (bFGF) or Angiopoietin-2 (Ang-2) in Patients with Chro
- THE SIGNIFICANCE OF TWO DIFFERENT FREE LIGHT CHAIN IMMUNOASSAYS FOR MONITORING OF DISEASE ACTIVITY IN MULTIPLE MYELOMA PATIENTS
- THE USE OF BIOCHEMICAL MARKERS, ECHOCARDIOGRAPHY AND ELECTROCARDIOGRAPHY IN THE ASSESSMENT OF CARDIOTOXICITY IN PATIENTS TREATED FOR ACUTE LEUKEMIA
- THE USE OF CARDIAC BIOMARKERS IN DETECTION OF CARDIOTOXICITY ASSOCIATED WITH CONVENTIONAL AND HIGH-DOSE CHEMOTHERAPY FOR ACUTE LEUKEMIA
- Úskalí léčby difúzního B-velkobuněčného Nehodgkinova lymfomu u nemocného s Jobovým syndromem
- Vliv onkologické léčby na cirkulující markery srdečního poškození v peritransplantačním období u akutních leukémií
- WAA APHERESIS REGISTER – RESULTS IN CZECH REPUBLIC
- Zvýšená exprese mRNA pro Angiopoietin-2 u pacientů s chronickou lymfocytární leukémií a nemutovaným IgVH
